JosephBowersCiolinoMD
Ophthalmology • Boston, MACataract Related, Cornea & External Disease
Instructor, Ophthalmology, Harvard Medical School
Dr. Ciolino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
325 Charles Street
Boston, MA 02114Phone+1 617-573-4443Fax+1 617-573-4444- Is this information wrong?
Education & Training
Albany Medical CenterResidency, Ophthalmology, 2004 - 2007
Brown UniversityInternship, Internal Medicine, 2002 - 2003
Georgetown University School of MedicineClass of 2002
Certifications & Licensure
NH State Medical License 2023 - 2025
MA State Medical License 2003 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis Start of enrollment: 2012 Mar 01
- A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival Start of enrollment: 2014 Apr 01
- Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Acute Corneal Edema in a Middle-Aged Patient.Jennifer A Tran, Aaron R Kaufman, Joseph B Ciolino> ;JAMA Ophthalmology. 2024 May 2
- Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.Thomas H Dohlman, Rohan Bir Singh, Francisco Amparo, Tatiana Carreno-Galeano, Mohammad Dastjerdi, Giulia Coco, Antonio Di Zazzo, Hasanain Shikari, Ujwala Saboo, Kimber...> ;Ophthalmology Science. 2024 Feb 13
- Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.Simmons, B., Gaddie, I., Holdbrook, M., Baba, S., Jalalat, P., Sadri, E., Paauw, J., Ciolino, J., Nijm, L., Meyer, J., Berdy, G., Yeu, E.> ;Cornea. 2024 Feb 9
- Join now to see all
Press Mentions
Seeking the Holy Grail Treatment for EndophthalmitisFebruary 19th, 2020
An Advance for Drug-Eluting Contact Lenses: Delivery to the Back of the EyeOctober 2nd, 2019
Innovation Sighting: Task Unification and Drug Dispensing Contact LensesSeptember 5th, 2016- Join now to see all
Grant Support
- Drug Eluting Contact LensesNational Eye Institute2009–2011
Professional Memberships
- Fellow
Hospital Affiliations
Massachusetts Eye and EarBoston, Massachusetts
Massachusetts General HospitalBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
